ElevateBio enters the cell and gene therapy market with startup portfolio

摘要

UK ElevateBio, a new US-based biotechnology holding company, has announced intentions to create and build a broad portfolio of cell and gene therapy companies through partnerships with leading academic researchers, medical centres and entrepreneurs.The business model is structured to build single- and multi-product cell and gene therapy companies by providing scientific founders with centralised bench-to-bedside capabilities including world-class scientists, manufacturing facilities, drug development and commercialisation expertise.